Mitigating cost increases through preemptive care and clinical efficacy to reduce the disease burden of clinically at-risk patients.
Lonny Reisman, MD, Chief Executive Officer, HealthReveal
Advertisement
Articles by Lonny Reisman, MD, Chief Executive Officer, HealthReveal
Advertisement
Latest Updated Articles
- Clinical Efficacy: A Cost Containment Weapon for the 21st Century
Published: August 18th 2015 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
FDA to Remove Black Box Warnings From HRT, Debate Ensues
2
High Fiber Linked to Fewer Bowel Symptoms in CRC Survivors
3
A Prescription for Improving Biomarker Testing for More Patients
4
Risk-Based Contracts May Not Cut Low-Value Care in Medicare Advantage
5
